Strategically targeting MYC in cancer [version 1; referees: 2 approved]
MYC is a major driver of cancer cell growth and mediates a transcriptional program spanning cell growth, the cell cycle, metabolism, and cell survival. Many efforts have been made to deliberately target MYC for cancer therapy. A variety of compounds have been generated to inhibit MYC function or sta...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
F1000 Research Ltd
2016-03-01
|
| Rangatū: | F1000Research |
| Ngā marau: | |
| Urunga tuihono: | http://f1000research.com/articles/5-408/v1 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|